Wyrorab-DSR Capsules

Wyrorab-DSR Capsules are a fixed-dose combination of a proton pump inhibitor (Rabeprazole Sodium – enteric coated) and a prokinetic agent (Domperidone – sustained release). This combination provides effective and long-lasting relief from acid-related disorders by reducing gastric acid secretion and improving gastrointestinal motility.

Wyrorab-DSR is indicated in the management of GERD (acid reflux disease), heartburn, hyperacidity, gastritis, peptic ulcer disease, and symptoms associated with delayed gastric emptying such as nausea, bloating, and fullness.

Rabeprazole suppresses excess acid production, while Domperidone enhances gastric emptying and prevents reflux, offering dual action for superior symptom control.

---

Composition (Each hard gelatin capsule contains):

• Rabeprazole Sodium IP …… 20 mg
  (as enteric-coated pellets)

• Domperidone IP …… 30 mg
  (as sustained-release pellets)

• Excipients …… q.s.

• Approved colour used in empty hard gelatin capsule shells & pellets

---

Key Benefits:

• Effectively controls acid reflux and heartburn

• Reduces gastric acid secretion

• Improves gastric motility and emptying

• Relieves nausea, bloating, and epigastric discomfort

• Provides prolonged symptom relief due to SR formulation

---

Indications:

• Gastro-esophageal reflux disease (GERD)

• Hyperacidity and heartburn

• Acid peptic disorders

• Gastritis and duodenal ulcer

• Reflux-associated nausea and vomiting

---

Dosage:

• As directed by the Physician

• Usually taken once daily before food

---

Directions for Use:

• Capsules should be swallowed whole

• Do not open, chew, or crush the capsule

---

Storage:

• Store in a cool, dry, and dark place

• Protect from light

• Keep out of reach of children

---

Pack Details:

• Dosage Form: Capsules

• Packing: 20 × 10 Capsules

• Route of Administration: Oral